These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31308625)
21. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study. Lee SK; Shin K; Jung JY; Suh CH; Kim JW; Kim HA BioDrugs; 2023 Mar; 37(2):247-257. PubMed ID: 36757601 [TBL] [Abstract][Full Text] [Related]
22. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Koduri G; Norton S; Young A; Cox N; Davies P; Devlin J; Dixey J; Gough A; Prouse P; Winfield J; Williams P; Rheumatology (Oxford); 2010 Aug; 49(8):1483-9. PubMed ID: 20223814 [TBL] [Abstract][Full Text] [Related]
23. [Interstitial lung disease and anti-TNF-alpha therapy in rheumatoid arthritis: Two different patterns?]. Schuller A; Coudurier M; Lega JC; Khouatra C; Cottin V; Cordier JF Rev Mal Respir; 2010 Mar; 27(3):232-7. PubMed ID: 20359615 [TBL] [Abstract][Full Text] [Related]
24. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study. Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347 [TBL] [Abstract][Full Text] [Related]
25. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor. Boyce EG; Halilovic J; Stan-Ugbene O Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591 [TBL] [Abstract][Full Text] [Related]
26. Association between anti-TNF-α therapy and interstitial lung disease. Herrinton LJ; Harrold LR; Liu L; Raebel MA; Taharka A; Winthrop KL; Solomon DH; Curtis JR; Lewis JD; Saag KG Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):394-402. PubMed ID: 23359391 [TBL] [Abstract][Full Text] [Related]
27. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Akiyama M; Kaneko Y Autoimmun Rev; 2022 May; 21(5):103056. PubMed ID: 35121155 [TBL] [Abstract][Full Text] [Related]
28. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583 [TBL] [Abstract][Full Text] [Related]
29. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586 [TBL] [Abstract][Full Text] [Related]
30. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity. van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908 [TBL] [Abstract][Full Text] [Related]
31. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Dai Y; Wang W; Yu Y; Hu S Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076 [TBL] [Abstract][Full Text] [Related]
32. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol. Migita K; Tsuji Y; Hisatomi K; Shigeno R; Izumi Y; Iwanaga N; Koga T Mod Rheumatol; 2017 Nov; 27(6):1079-1082. PubMed ID: 26044288 [TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis. Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064 [TBL] [Abstract][Full Text] [Related]
34. Radiological evaluation of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept or JAK inhibitors for 1 year. Mochizuki T; Yano K; Ikari K; Okazaki K Respir Investig; 2023 May; 61(3):359-363. PubMed ID: 37031622 [TBL] [Abstract][Full Text] [Related]
35. Systematic review of the impact of drugs on diffuse interstitial lung disease associated with rheumatoid arthritis. Carrasco Cubero C; Chamizo Carmona E; Vela Casasempere P Reumatol Clin (Engl Ed); 2021 Nov; 17(9):504-513. PubMed ID: 34756311 [TBL] [Abstract][Full Text] [Related]
36. Rheumatoid Arthritis Interstitial Lung Disease: Measuring and Predictive Factors Among Patients Treated in Rehabilitation Clinics at Royal Medical Services. Alsharari DM; Obeidat LA; Khasawneh HK; Alhmar MRH; Khasawneh RM; Bataineh ZS; Aldhoun AA Med Arch; 2020 Dec; 74(6):450-454. PubMed ID: 33603270 [TBL] [Abstract][Full Text] [Related]
37. [Pulmonary involvement in rheumatoid arthritis]. Krause A; Rubbert-Roth A Z Rheumatol; 2019 Apr; 78(3):228-235. PubMed ID: 30887119 [TBL] [Abstract][Full Text] [Related]
38. Association between chest computed tomography findings and respiratory adverse events in rheumatoid arthritis patients undergoing long-term biological therapy. Matsumoto T; Iwano S; Takahashi N; Asai S; Watanabe T; Asai N; Sobue Y; Ito S; Ishiguro N; Kojima T Int J Rheum Dis; 2019 Apr; 22(4):626-635. PubMed ID: 30411520 [TBL] [Abstract][Full Text] [Related]
39. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082 [TBL] [Abstract][Full Text] [Related]
40. Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. Hallowell RW; Horton MR Drugs; 2014 Mar; 74(4):443-50. PubMed ID: 24570384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]